Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
about
Catestatin: a multifunctional peptide from chromogranin AChromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment.Cardiac electrical activity in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertensionObligatory role for endothelial heparan sulphate proteoglycans and caveolae internalization in catestatin-dependent eNOS activationNaturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart.A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardiumProteomic analysis yields an unexpected trans-acting point in control of the human sympathochromaffin phenotype.Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinedionesPlasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia.Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling.Chromogranin A and derived peptides in health and diseaseNovel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertensionThe relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol.Increased plasma level of catestatin might be associated with poor prognosis in hemodialysis patients.Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity.Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway.Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin.Catestatin, a chromogranin A-derived peptide, is sympathoinhibitory and attenuates sympathetic barosensitivity and the chemoreflex in rat CVLM.Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex.Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion.Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure.Cardiomyokines from the heart.Chronic Administration of Catestatin Improves Autonomic Function and Exerts Cardioprotective Effects in Myocardial Infarction Rats.Catestatin Induces Glucose Uptake and GLUT4 Trafficking in Adult Rat CardiomyocytesCatestatin as a Target for Treatment of Inflammatory Diseases
P2860
Q33838302-1362DA09-F954-4733-B2AC-F8F451D467A0Q33874523-20D78B6B-26B7-4C14-83E9-92C6A5047866Q33911405-3EB1260F-24A9-4640-A0CE-CA2B222C4390Q34022482-62B9286B-DC84-4ED3-8DB2-9B18C53D4681Q34435126-A9E0FD82-C86C-40E3-85BD-7DBEF0DBE282Q34435168-EA3A78E2-DAC1-4436-B5C0-50206C23F8CBQ35167066-5FAABB36-2626-4966-BC47-2B5842E3746BQ35871167-3E561C5B-06FF-4073-ACA8-94F365980049Q36050852-FCE071BE-8E77-490A-9EAF-57EFD6BCA123Q36052958-DE02DE3D-FAF3-4E44-9F36-9A7C4112F3B3Q36080486-5C2EB5C6-D12F-4A50-A96E-1C5F02E36BCFQ36110075-16735CC9-5F9A-408E-8608-760E43F5352CQ36470847-228977A6-0F59-4A31-916D-2537FC44A537Q37680653-7601C86C-1DC5-489F-91CE-EA4644A7C40AQ38761432-2EAE5533-F754-4AC4-BCEA-8888D50B8A59Q39147191-B5F05C28-3EE9-47F1-A974-CD924E681BCEQ40690975-E2FD85BD-444B-4437-A648-55A531A07A57Q41138497-E2E2F491-1A7C-4671-ACDE-5101EA93E336Q42496988-ABED687B-0639-46AE-B04F-00F457BA3C21Q42498258-603752AA-4CAF-4358-B83E-47EF1321D63FQ42868143-DFAF47BC-1E5C-427F-8B3E-B91B57228C71Q46178248-150E43C4-BAB1-41CA-A6DD-D02825A82A0DQ47702359-FEBE5F88-071F-4480-AAE4-62C0D7EFA3B1Q47916949-E253B8DF-1D76-41D7-85BB-FDD600B43D2AQ53195201-3C5BBB8B-8169-439F-8D6A-299ED5B4109FQ58123760-46258627-3998-4B6E-B6CD-01742B737457Q58583898-9792FD49-1417-4F38-AAAC-F83258E4C9E5
P2860
Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global disturbances in autonom ...... the chromogranin a null mouse.
@en
Global disturbances in autonom ...... the chromogranin a null mouse.
@nl
type
label
Global disturbances in autonom ...... the chromogranin a null mouse.
@en
Global disturbances in autonom ...... the chromogranin a null mouse.
@nl
prefLabel
Global disturbances in autonom ...... the chromogranin a null mouse.
@en
Global disturbances in autonom ...... the chromogranin a null mouse.
@nl
P2093
P2860
P356
P1433
P1476
Global disturbances in autonom ...... the chromogranin a null mouse.
@en
P2093
Daniel T O'Connor
Jiaur R Gayen
Sushil K Mahata
P2860
P304
P356
10.1210/EN.2009-0429
P407
P577
2009-10-09T00:00:00Z